WallStSmart
PLRZ

Polyrizon Ltd. Ordinary Shares

NASDAQ: PLRZ · HEALTHCARE · BIOTECHNOLOGY

$16.12
-4.90% today

Updated 2026-06-04

Market cap
$27.97M
P/E ratio
P/S ratio
EPS (TTM)
$-4.90
Dividend yield
52W range
$3 – $18
Volume
0.0M

Polyrizon Ltd. Ordinary Shares (PLRZ) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item202020212022202320242025
Total assets$24000.00$687000.00$546000.00$559000.00$5.55M$21.44M
Cash & equivalents$10000.00$523000.00$36000.00$4000.00$2.55M$1.31M
Current assets$19000.00$544000.00$51000.00$54000.00$2.65M$12.86M
Total liabilities$8000.00$690000.00$1.20M$750000.00$261000.00$443000.00
Current liabilities$8000.00$690000.00$1.20M$502000.00$261000.00$443000.00
Long-term debt
Shareholder equity$16000.00$-3000.00$-652000.00$57000.00$5.29M$20.99M
Retained earnings$-1.43M$-2.14M$-2.92M$-3.52M$-5.07M$-8.40M
Accounts receivable
Inventory
Goodwill

Frequently asked questions

How much free cash flow does PLRZ generate?

PLRZ produced $-4.54M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PLRZ's balance sheet healthy?

PLRZ holds $1.31M in cash and equivalents against — in long-term debt, on $20.99M of shareholder equity. That debt is best read against the cash flow the business throws off each year.